Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FDA awards 15 grants for clinical trials to stimulate product development for rare diseases

      FDA awards 15 grants for clinical trials to stimulate product development for rare diseases

      Ruby Khatun Khatun9 Oct 2017 9:47 AM IST
      The U.S. Food and Drug Administration (FDA) announced that it has awarded 15 new clinical trial research grants totaling more than $22 million over...
      Bayer sticks by Xarelto sales estimate despite study setback

      Bayer sticks by Xarelto sales estimate despite study setback

      Ruby Khatun Khatun9 Oct 2017 9:20 AM IST
      FRANKFURT/BERLIN: Bayer stood by its peak sales estimate for clot prevention drug Xarelto after the pill disappointed in a late-stage trial to test...
      Why shift in drug pricing policy: SC asks Centre

      Why shift in drug pricing policy: SC asks Centre

      Ruby Khatun Khatun8 Oct 2017 12:06 PM IST
      New Delhi: A bench of Supreme Court headed by Chief Justice Dipak Misra, Justice A.M. Khanwilkar and Justice D.Y. Chandrachud recently asked the...
      FDA approves first test for screening Zika virus in blood donations

      FDA approves first test for screening Zika virus in blood donations

      Ruby Khatun Khatun8 Oct 2017 10:15 AM IST
      The U.S. Food and Drug Administration approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual...
      Granules India gets EIR from USFDA for Vizag OmniChem facility

      Granules India gets EIR from USFDA for Vizag OmniChem facility

      Ruby Khatun Khatun8 Oct 2017 10:01 AM IST
      New Delhi: Drug firm Granules India said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility...
      Johnson and Johnson unit exits insulin pump business amid rising competition

      Johnson and Johnson unit exits insulin pump business amid rising competition

      Ruby Khatun Khatun8 Oct 2017 10:00 AM IST
      Johnson and Johnson’s diabetes care unit, which makes insulin pumps, said on Thursday it would shut its business in the United States and Canada amid...
      At least six funds interested in Sanofi European generic drugs unit -Le Figaro

      At least six funds interested in Sanofi European generic drugs unit -Le Figaro

      Ruby Khatun Khatun8 Oct 2017 9:45 AM IST
      PARIS: French pharmaceutical group Sanofi is set to start the process to sell its generic drug business in Europe, and at least six funds have...
      Eli Lilly defeats challenge to Alimta cancer drug patent

      Eli Lilly defeats challenge to Alimta cancer drug patent

      Ruby Khatun Khatun8 Oct 2017 9:30 AM IST
      A federal patent review board on Thursday rejected a challenge to a patent covering Eli Lilly and Co’s Alimta drug to treat some lung cancers and...
      Roche bladder cancer drug struggles as medics focus on survival

      Roche bladder cancer drug struggles as medics focus on survival

      Ruby Khatun Khatun8 Oct 2017 9:15 AM IST
      LONDON: Roche’s immunotherapy drug Tecentriq has lost market share to Merck & Co’s rival Keytruda since a clinical trial showed the Swiss...
      Teva faces generic competition in Europe for Copaxone after US hit

      Teva faces generic competition in Europe for Copaxone after US hit

      Ruby Khatun Khatun8 Oct 2017 9:00 AM IST
      LONDON: Teva’s blockbuster multiple sclerosis treatment Copaxone will face additional generic competition in Europe, just two days after Mylan NV won...
      FIR against Hetero and Aurobindo pharma

      FIR against Hetero and Aurobindo pharma

      Ruby Khatun Khatun7 Oct 2017 1:36 PM IST
      HYDERABAD: 13 pharmaceutical companies have got notices from Telangana State Pollution Control Board (TSPCB) for contaminating and polluting Kazipally...
      Safe, effective DNA-based Zika vaccine developed

      Safe, effective DNA-based Zika vaccine developed

      Ruby Khatun Khatun7 Oct 2017 10:58 AM IST
      Washington: A new generation DNA-based Zika vaccine has been found safe and effective at eliciting an immune response against the virus in early human...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok